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Background: Amaternal primary cytomegalovirus (CMV) infec-
tion during pregnancy is more likely to transmit CMV from mother
to fetus with more severe sequelae of congenital infection com-
pared with a maternal non-primary CMV infection (reinfection
or reactivation). The aim of this study is the evaluation of CMV
seroprevalence and susceptibility to primary CMV infection among
Greek and immigrant pregnant and non-pregnantwomenof repro-
ductive age.
Methods & Materials: From January 2011 to September 2013,
a total of 3,121 pregnant and non-pregnant women of childbear-
ing age, were tested for CMV-IgG and IgM antibodies. Out of 3,121
women the 1,683 were Greeks and 1,438 were immigrants from
developingcountries.Of the1,683Greeksand1,438 immigrants the
755 and 815 respectivelywere pregnant. Detection of CMV-speciﬁc
IgG and IgM antibodies was carried out by EIA and electrochemi-
luminescence immunoassay (ABBOTT, AxSYM CMV IgG and IgM
Microparticle Enzyme Immunoassay and Roche CMV IgG and IgM
electrochemiluminescence immunoassay on cobas e 411 analyzer)
according to the manufacturer’s instructions.
Results: CMV-IgG and IgM antibodies were detected in 617
(66.49%) and 7 (0.75%) non-pregnant and 537 (71.12%) and 2
(0.26%) pregnant Greek women respectively, whereas CMV IgG
and IgM antibodies were detected in 581 (93.26%) and 7 (1.12%)
non-pregnant and 789 (96.81%) and 1 (0.12%) pregnant immigrant
women respectively. The susceptibility to primary CMV infection of
non-pregnant and pregnant Greek women was found to be 33.51%
(311/928) and 28.88% (218/755) respectively, whereas the sus-
ceptibility to primary CMV infection of no-pregnant and pregnant
immigrant women was 6.74% (42/623) and 3.19% (26/815) respec-
tively. Statistical analysis by x2 test showed signiﬁcantly higher
susceptibility to primary CMV infection in non-pregnant and
pregnant Greek women than in immigrant women.
Conclusion: (a) The prevalence of speciﬁc antibodies to CMV in
pregnant and non-pregnant Greek women of childbearing age is
high. (b) The CMV seroprevalence in pregnant and non-pregnant
immigrant women is signiﬁcantly higher than in Greek women. (c)
The susceptibility to primary CMV infection is signiﬁcantly higher
in pregnant and non-pregnant Greek women than in immigrants.
(d) A remarkable number of Greek women of reproductive age
remain at risk of primary CMV infection during pregnancy.
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Diagnostic considerations in a patient with
leukemia and diffuse spinal cord enhancement
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Background: A 66 year old male with history of hairy cell
leukemia presented with high grade fevers, nausea, vomiting, rash
on bilateral lower extremities and unilateral left leg weakness that
started a few days ago.
He was in Texas a week ago, where he was hunting in a forest
with heavymosquito and tick burden. Hewas not on any treatment
for hairy cell leukemia, diagnosed three years ago.
On examination, the patientwas febrile (101.0 0F); tachycardiac
(130/minute) and lethargic. Hewas oriented to time, place and per-
son. Chest was clear. Nomurmurswere appreciated. Abdomenwas
ﬁrm with splenomegaly. Motor strength of the left leg was signif-
icantly less than the right. Faint bilateral petechiae were apparent
on bilateral calves and feet.
Laboratory work up: WBC count 3400 mm3/dl; hemoglobin
14.2 g/dl; platelets 64,000/mm3. Liver and renal function testswere
unremarkable. Chest radiograph did not reveal any consolidation.
MRI of the head did not show gross pathology, while lumbar and
thoracic spine showed diffuse signal abnormality on T2 weighted
images. Lumbar puncture showed WBC 315 (40% lymphocytes);
glucose 54; protein 227.
Methods & Materials: Patient was empirically treated with
doxycycline and high dose steroids and IVIG. Patient was observed
in the ICU, where he was brieﬂy intubated.
Results: Serumserologies for RMSF and Lymediseasewere neg-
ative. CMV,HSV andVZV antibodieswere absent in the CSF, aswere
bacterial and fungal cultures. West Nile virus IgM was elevated in
CSF and serum.
Conclusion: Acutemotorweakness, fevers, rash and spinal cord
enhancement in a patient with leukemia and signiﬁcant vector
exposure poses a diagnostic challenge. Initial therapy should be
directed towards possible paraneoplastic syndrome and treatable
infectious etiologies affecting the spine, such as neuroborrelio-
sis and RMSF. Other viral etiologies were less likely and usually
affect immunosuppressed hosts. This is a unique case of West Nile
myelitis without signiﬁcant brain involvement, presenting with
unilateral weakness and petechial rash. Unfortunately there is no
deﬁnite therapy for this dangerous virus. In our patient, aggres-
sive supportive care and timely diagnosis resulted in a favorable
outcome and clinical stability.
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